Bank Of Montreal

Direxion Daily Small Cap Bull 3X ETF

SPDR S&P Retail ETF

ProShares UltraPro Dow30

ProShares UltraShort Bloomberg Natrl Gas

Guggenheim Solar ETF

Direxion Technology Bear 3X Shares

Materials Select Sector SPDR

ProShares Trust ProShares Short Bitcoin Strategy ETF

ProShares Bitcoin Strategy ETF

Direxion Daily Small Cap Bear 3X ETF

ProShares Ultra Bloomberg Natural Gas

Direxion Daily Technology Bull 3X ETF

ARK Innovation ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

Magal Security Systems Ltd.

Direxion Financial Bear 3X Shar

Direxion Daily Semicondct Bull 3X ETF

JELD-WEN Holding Inc. Common Stock

Las Vegas Sands Corp. Common Stock

Century Communities Inc. Common Stock

Kontoor Brands Inc. Common Stock

Bath & Body Works Inc.

RLJ Lodging Trust Common Shares of Beneficial Interest $0.01 par value

Leggett & Platt Incorporated Common Stock

Snap Inc. Class A Common Stock

Cleveland-Cliffs Inc. Common Stock

Civitas Resources Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

AMC Entertainment Holdings Inc. Class A Common Stock

Oklo Inc.

QuantumScape Corporation Class A Common Stock

Sea Limited American Depositary Shares each representing one Class A Ordinary Share

Cameco Corporation Common Stock

Twilio Inc. Class A Common Stock

Spotify Technology S.A. Ordinary Shares

Cloudflare Inc. Class A Common Stock

Molina Healthcare Inc Common Stock

Click here to get full coverage on 5am Ventures v sells Entrada Therapeutics (TRDA) stock for $202k - Investing.com

5am Ventures v sells Entrada Therapeutics (TRDA) stock for $202k  Investing.com

5am Ventures v sells Entrada Therapeutics (TRDA) stock for $202k - Investing.com

Click here to get full coverage on 2025 Tennessee Rental Dealers Association (TRDA) Annual Meeting - rtohq.org

2025 Tennessee Rental Dealers Association (TRDA) Annual Meeting  rtohq.org

2025 Tennessee Rental Dealers Association (TRDA) Annual Meeting - rtohq.org

Click here to get full coverage on (TRDA) Investment Analysis and Advice - news.stocktradersdaily.com

(TRDA) Investment Analysis and Advice  news.stocktradersdaily.com

(TRDA) Investment Analysis and Advice - news.stocktradersdaily.com

Click here to get full coverage on Entrada Therapeutics, Inc. (TRDA): A Cheap Biotech Stock to Invest In Now - Yahoo Finance

Entrada Therapeutics, Inc. (TRDA): A Cheap Biotech Stock to Invest In Now  Yahoo Finance

Entrada Therapeutics, Inc. (TRDA): A Cheap Biotech Stock to Invest In Now - Yahoo Finance

Click here to get full coverage on Entrada Therapeutics Reports First Quarter 2025 Financial Results - Stock Titan

Entrada Therapeutics Reports First Quarter 2025 Financial Results  Stock Titan

Entrada Therapeutics Reports First Quarter 2025 Financial Results - Stock Titan

Click here to get full coverage on Entrada therapeutics (TRDA) director Parmar sells $202k in stock By Investing.com - Investing.com South Africa

Entrada therapeutics (TRDA) director Parmar sells $202k in stock By Investing.com  Investing.com South Africa

Entrada therapeutics (TRDA) director Parmar sells $202k in stock By Investing.com - Investing.com South Africa

Click here to get full coverage on Is Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Recent Stock Performance Tethered To Its Strong Fundamentals? - simplywall.st

Is Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Recent Stock Performance Tethered To Its Strong Fundamentals?  simplywall.st

Is Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Recent Stock Performance Tethered To Its Strong Fundamentals? - simplywall.st

Click here to get full coverage on Know Your Tip Reporting Rights - Restaurant Hospitality

Know Your Tip Reporting Rights  Restaurant Hospitality

Know Your Tip Reporting Rights - Restaurant Hospitality

Click here to get full coverage on HRMY: 3 Emerging Biotech Stocks Developing Breakthrough Therapies - StockNews

HRMY: 3 Emerging Biotech Stocks Developing Breakthrough Therapies  StockNews

HRMY: 3 Emerging Biotech Stocks Developing Breakthrough Therapies - StockNews

Click here to get full coverage on Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - TradingView

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)  TradingView

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - TradingView

Click here to get full coverage on Ex-Biogen Chief Medical Officer Strengthens Entrada's Duchenne Program as Phase 1 Data Shows Promise - Stock Titan

Ex-Biogen Chief Medical Officer Strengthens Entrada's Duchenne Program as Phase 1 Data Shows Promise  Stock Titan

Ex-Biogen Chief Medical Officer Strengthens Entrada's Duchenne Program as Phase 1 Data Shows Promise - Stock Titan

Click here to get full coverage on Biotech Stock Roundup: BLUE Down on Update, News From GILD, TRDA - Yahoo Finance

Biotech Stock Roundup: BLUE Down on Update, News From GILD, TRDA  Yahoo Finance

Biotech Stock Roundup: BLUE Down on Update, News From GILD, TRDA - Yahoo Finance

Click here to get full coverage on BlackRock, Inc. Increases Stake in Entrada Therapeutics Inc - GuruFocus

BlackRock, Inc. Increases Stake in Entrada Therapeutics Inc  GuruFocus

BlackRock, Inc. Increases Stake in Entrada Therapeutics Inc - GuruFocus

Click here to get full coverage on Entrada Therapeutics (TRDA) 10% owners sell $866k in stock - Investing.com

Entrada Therapeutics (TRDA) 10% owners sell $866k in stock  Investing.com

Entrada Therapeutics (TRDA) 10% owners sell $866k in stock - Investing.com

Click here to get full coverage on Entrada Therapeutics Awards Nearly 24,000 RSUs in Latest Employee Compensation Plan - Stock Titan

Entrada Therapeutics Awards Nearly 24,000 RSUs in Latest Employee Compensation Plan  Stock Titan

Entrada Therapeutics Awards Nearly 24,000 RSUs in Latest Employee Compensation Plan - Stock Titan

Click here to get full coverage on HRMY: 3 Small-Cap Biotech Stocks to Buy for Major Upside - StockNews

HRMY: 3 Small-Cap Biotech Stocks to Buy for Major Upside  StockNews

HRMY: 3 Small-Cap Biotech Stocks to Buy for Major Upside - StockNews

Click here to get full coverage on Breakthrough DMD Treatment Gets EU Green Light: Entrada's Novel Exon 45 Therapy Heads to Clinical Trials - Stock Titan

Breakthrough DMD Treatment Gets EU Green Light: Entrada's Novel Exon 45 Therapy Heads to Clinical Trials  Stock Titan

Breakthrough DMD Treatment Gets EU Green Light: Entrada's Novel Exon 45 Therapy Heads to Clinical Trials - Stock Titan

Click here to get full coverage on Entrada Therapeutics, Inc. SEC 10-K Report - TradingView

Entrada Therapeutics, Inc. SEC 10-K Report  TradingView

Entrada Therapeutics, Inc. SEC 10-K Report - TradingView

Click here to get full coverage on Entrada Therapeutics stock hits 52-week low at $9.74 By Investing.com - Investing.com UK

Entrada Therapeutics stock hits 52-week low at $9.74 By Investing.com  Investing.com UK

Entrada Therapeutics stock hits 52-week low at $9.74 By Investing.com - Investing.com UK

Click here to get full coverage on Entrada Therapeutics earnings beat by $0.31, revenue topped estimates - Investing.com UK

Entrada Therapeutics earnings beat by $0.31, revenue topped estimates  Investing.com UK

Entrada Therapeutics earnings beat by $0.31, revenue topped estimates - Investing.com UK

Click here to get full coverage on CM Saha attends annual conference of Tripura Retired Doctors' Association - ANI News

CM Saha attends annual conference of Tripura Retired Doctors' Association  ANI News

CM Saha attends annual conference of Tripura Retired Doctors' Association - ANI News

Click here to get full coverage on Virtual reality as a potential therapy in a rehabilitation sanatorium for patients after ischemic stroke: impact on quality of life and social participation - a randomized trial - Frontiers

Virtual reality as a potential therapy in a rehabilitation sanatorium for patients after ischemic stroke: impact on quality of life and social participation - a randomized trial  Frontiers

Virtual reality as a potential therapy in a rehabilitation sanatorium for patients after ischemic stroke: impact on quality of life and social participation - a randomized trial - Frontiers

Click here to get full coverage on Entrada Therapeutics: Pioneering a New Era in Duchenne Muscular Dystrophy Treatment - AInvest

Entrada Therapeutics: Pioneering a New Era in Duchenne Muscular Dystrophy Treatment  AInvest

Entrada Therapeutics: Pioneering a New Era in Duchenne Muscular Dystrophy Treatment - AInvest

Click here to get full coverage on Entrada Therapeutics Reports First Quarter 2025 Financial Results - The Manila Times

Entrada Therapeutics Reports First Quarter 2025 Financial Results  The Manila Times

Entrada Therapeutics Reports First Quarter 2025 Financial Results - The Manila Times

Click here to get full coverage on Entrada Therapeutics (TRDA) Earnings Date and Reports 2025 - MarketBeat

Entrada Therapeutics (TRDA) Earnings Date and Reports 2025  MarketBeat

Entrada Therapeutics (TRDA) Earnings Date and Reports 2025 - MarketBeat

Click here to get full coverage on 2 Biotech Stocks to Buy, 1 to Sell Now - TradingView

2 Biotech Stocks to Buy, 1 to Sell Now  TradingView

2 Biotech Stocks to Buy, 1 to Sell Now - TradingView

Click here to get full coverage on Entrada Therapeutics Director Kim Peter S Acquires 1,512 Shares - TradingView

Entrada Therapeutics Director Kim Peter S Acquires 1,512 Shares  TradingView

Entrada Therapeutics Director Kim Peter S Acquires 1,512 Shares - TradingView

Click here to get full coverage on Entrada Therapeutics (TRDA) Insider Trading Activity 2025 - MarketBeat

Entrada Therapeutics (TRDA) Insider Trading Activity 2025  MarketBeat

Entrada Therapeutics (TRDA) Insider Trading Activity 2025 - MarketBeat

Click here to get full coverage on Azenta Announces the Election of Dipal Doshi to its Board of Directors - BioSpace

Azenta Announces the Election of Dipal Doshi to its Board of Directors  BioSpace

Azenta Announces the Election of Dipal Doshi to its Board of Directors - BioSpace

Click here to get full coverage on Are These 3 Biotech Stocks Good Buys? - Entrepreneur

Are These 3 Biotech Stocks Good Buys?  Entrepreneur

Are These 3 Biotech Stocks Good Buys? - Entrepreneur

Click here to get full coverage on IRS proposes new tip reporting program that would affect restaurants, tipped workers - National Restaurant Association

IRS proposes new tip reporting program that would affect restaurants, tipped workers  National Restaurant Association

IRS proposes new tip reporting program that would affect restaurants, tipped workers - National Restaurant Association

Click here to get full coverage on Partisan Posts Misrepresent IRS’ Voluntary Program Proposal on Tip Income - FactCheck.org

Partisan Posts Misrepresent IRS’ Voluntary Program Proposal on Tip Income  FactCheck.org

Partisan Posts Misrepresent IRS’ Voluntary Program Proposal on Tip Income - FactCheck.org

Click here to get full coverage on Showcase 2025 - Graduate Studies - Trinity College Dublin

Showcase 2025 - Graduate Studies  Trinity College Dublin

Showcase 2025 - Graduate Studies - Trinity College Dublin

Click here to get full coverage on Huge Huawei Watch 5 leak suggests smartwatch will arrive soon - Wareable

Huge Huawei Watch 5 leak suggests smartwatch will arrive soon  Wareable

Huge Huawei Watch 5 leak suggests smartwatch will arrive soon - Wareable

Click here to get full coverage on Doctoral student Luke Gibbons gets honour - Graduate Studies - Trinity College Dublin

Doctoral student Luke Gibbons gets honour - Graduate Studies  Trinity College Dublin

Doctoral student Luke Gibbons gets honour - Graduate Studies - Trinity College Dublin

Click here to get full coverage on Decision-Making for People with Advanced Illness in Palliative Care - Trinity College Dublin

Decision-Making for People with Advanced Illness in Palliative Care  Trinity College Dublin

Decision-Making for People with Advanced Illness in Palliative Care - Trinity College Dublin

Click here to get full coverage on Entrada Therapeutics earnings missed by $0.12, revenue topped estimates - Investing.com Nigeria

Entrada Therapeutics earnings missed by $0.12, revenue topped estimates  Investing.com Nigeria

Entrada Therapeutics earnings missed by $0.12, revenue topped estimates - Investing.com Nigeria

Click here to get full coverage on Nothing Phone 3a Surfaces on TDRA Certification Site Ahead of March 4 Launch - Gadgets 360

Nothing Phone 3a Surfaces on TDRA Certification Site Ahead of March 4 Launch  Gadgets 360

Nothing Phone 3a Surfaces on TDRA Certification Site Ahead of March 4 Launch - Gadgets 360

Click here to get full coverage on Figure 1: Scheme representing the most important plant PRR with known... - researchgate.net

Figure 1: Scheme representing the most important plant PRR with known...  researchgate.net

Figure 1: Scheme representing the most important plant PRR with known... - researchgate.net

Click here to get full coverage on UAE: Ministry of Economy, TDRA impose strict rules, heavy fines to rein in telemarketers - Gulf Business

UAE: Ministry of Economy, TDRA impose strict rules, heavy fines to rein in telemarketers  Gulf Business

UAE: Ministry of Economy, TDRA impose strict rules, heavy fines to rein in telemarketers - Gulf Business

Click here to get full coverage on Oppo Reno 13 Pro Reportedly Spotted on BIS, Other Certification Sites; May Launch Soon - Gadgets 360

Oppo Reno 13 Pro Reportedly Spotted on BIS, Other Certification Sites; May Launch Soon  Gadgets 360

Oppo Reno 13 Pro Reportedly Spotted on BIS, Other Certification Sites; May Launch Soon - Gadgets 360

Click here to get full coverage on UAE issues new telemarketing rules, heavy penalties - ZAWYA

UAE issues new telemarketing rules, heavy penalties  ZAWYA

UAE issues new telemarketing rules, heavy penalties - ZAWYA

Click here to get full coverage on What makes TRDA stock price move sharply - AI Powered Stock Call - Newser

What makes TRDA stock price move sharply - AI Powered Stock Call  Newser

What makes TRDA stock price move sharply - AI Powered Stock Call - Newser

Click here to get full coverage on Work starts to develop 'Tarabitan' near Tarapith temple at Rs 5.16 cr - MillenniumPost

Work starts to develop 'Tarabitan' near Tarapith temple at Rs 5.16 cr  MillenniumPost

Work starts to develop 'Tarabitan' near Tarapith temple at Rs 5.16 cr - MillenniumPost

Click here to get full coverage on How TRDA stock performs during market volatility - Massive Gain Ideas - Newser

How TRDA stock performs during market volatility - Massive Gain Ideas  Newser

How TRDA stock performs during market volatility - Massive Gain Ideas - Newser

Click here to get full coverage on Why TRDA stock attracts strong analyst attention - Investor Favorite Picks - Newser

Why TRDA stock attracts strong analyst attention - Investor Favorite Picks  Newser

Why TRDA stock attracts strong analyst attention - Investor Favorite Picks - Newser

Click here to get full coverage on Why TRDA stock attracts strong analyst attention - Best Stocks for Capital Safety - Newser

Why TRDA stock attracts strong analyst attention - Best Stocks for Capital Safety  Newser

Why TRDA stock attracts strong analyst attention - Best Stocks for Capital Safety - Newser

Click here to get full coverage on What makes TRDA stock price move sharply - Free Smart Money Group - Newser

What makes TRDA stock price move sharply - Free Smart Money Group  Newser

What makes TRDA stock price move sharply - Free Smart Money Group - Newser

Click here to get full coverage on Why TRDA stock attracts strong analyst attention - Smart High Yield Swing Trades - Newser

Why TRDA stock attracts strong analyst attention - Smart High Yield Swing Trades  Newser

Why TRDA stock attracts strong analyst attention - Smart High Yield Swing Trades - Newser

Click here to get full coverage on Entrada Therapeutics (NASDAQ:TRDA) Shares Down 3.6% – Should You Sell? - Defense World

Entrada Therapeutics (NASDAQ:TRDA) Shares Down 3.6% – Should You Sell?  Defense World

Entrada Therapeutics (NASDAQ:TRDA) Shares Down 3.6% – Should You Sell? - Defense World

Click here to get full coverage on Entrada Therapeutics (NASDAQ:TRDA) Upgraded to “Hold” at Wall Street Zen - Defense World

Entrada Therapeutics (NASDAQ:TRDA) Upgraded to “Hold” at Wall Street Zen  Defense World

Entrada Therapeutics (NASDAQ:TRDA) Upgraded to “Hold” at Wall Street Zen - Defense World

Click here to get full coverage on Nothing Phone (3a) secures TRDA certification ahead of launch - Gizmochina

Nothing Phone (3a) secures TRDA certification ahead of launch  Gizmochina

Nothing Phone (3a) secures TRDA certification ahead of launch - Gizmochina

Click here to get full coverage on Vivo’s Galaxy S25 Edge lookalike spotted on certification site with 5380mAh battery - Gizmochina

Vivo’s Galaxy S25 Edge lookalike spotted on certification site with 5380mAh battery  Gizmochina

Vivo’s Galaxy S25 Edge lookalike spotted on certification site with 5380mAh battery - Gizmochina

Click here to get full coverage on Condemned by TVA - Facing South

Condemned by TVA - Facing South

Click here to get full coverage on Motorola Edge 40 Neo and Motorola G84 spotted on TDRA certification, launch is imminent - The Tech Outlook

Motorola Edge 40 Neo and Motorola G84 spotted on TDRA certification, launch is imminent  The Tech Outlook

Entrada Therapeutics Inc (TRDA)

Price Chart

Key Statistics

Technicals

About TRDA

Latest News

5am Ventures v sells Entrada Therapeutics (TRDA) stock for $202k - Investing.com

2025 Tennessee Rental Dealers Association (TRDA) Annual Meeting - rtohq.org

(TRDA) Investment Analysis and Advice - news.stocktradersdaily.com

Advanced Charts

Top Gainers

Top Losers